Clinical trial
Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia
NCT00078182 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Withdrawn
Key facts
| NCT number | NCT00078182 |
|---|---|
| Title | Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia |
| Official title | Study of Daily Oral Tenofovir (Tenofovir Disoproxil Fumarate) to Prevent HIV-1 Infection Among Sex Workers in Cambodia |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | NCHADS - Ministry of Health of Cambodia Kirby Institute |
| Status | Withdrawn |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV Seronegativity |
| Intervention type | Drug |
| Interventions | Tenofovir DF |
| Enrollment | 0 |
| First posted | Feb 20, 2004 |
| Last update posted | Dec 14, 2016 |
| Countries | Cambodia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: